Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VCE vs VAD in Stage IV Childhood Renal Tumor
NCT03669783Phase 3Recruiting
- Sponsor
- Assistance Publique-Hôpitaux de Marseille
- Start
- Feb 2023
- Primary completion
- Oct 2028
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of carboplatin, etoposide in Wilms tumor (WT), sponsored by Assistance Publique-Hôpitaux de Marseille. Started Feb 2023; status: recruiting.
02
Drugs
carboplatinetoposide
03
Conditions
Wilms tumor (WT)
Beyond the preview
Go deeper on NCT03669783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03669783.